Medicure (TSE:MPH) has released an update.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Medicure Inc. has completed the acquisition of intellectual property from CanAm Bioresearch, securing new chemical entities that could revolutionize disease treatment pending further studies and regulatory approval. The deal includes initial cash payment and milestone payments, plus a share of future net proceeds relating to the assets, indicating a strong potential for future revenue growth.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.